Status:
COMPLETED
A Gender-Enhanced Pre-Exposure Prophylaxis (PrEP) Information-Motivational Workshop for Young South African Women
Lead Sponsor:
New York State Psychiatric Institute
Collaborating Sponsors:
Medical Research Council, South Africa
Brown University
Conditions:
HIV Infections
Eligibility:
FEMALE
18-25 years
Phase:
PHASE1
Brief Summary
This is a phase 1 pilot study to assess feasibility and acceptability and potential for impact of a gender-enhanced virtual group workshop focused on oral Pre-Exposure Prophylaxis (PrEP) as an HIV pre...
Detailed Description
South African adolescent girls and young women (AGYW) remain at extraordinarily high risk of HIV infection. Oral pre-exposure prophylaxis (PrEP) has the potential to alter the epidemic in this vulnera...
Eligibility Criteria
Inclusion
- self-reported HIV-negative or unknown status
- heterosexual vaginal or anal intercourse reported in the past 6 months
- Is not currently taking PrEP or planning to begin PrEP
- presently residing in eThekweni-metropolitan Durban
- has private smart-phone access
- Conversant in isiZulu or English
- Willing to recruit other women (if in first group of participants);
- (If recruited subsequent to first group): Recruited by a peer health advocate (someone the participant knew knew prior to being recruited)
Exclusion
- Overt signs of cognitive impairment
- Was a participant in the previously conducted focus groups
- If assigned to the online group intervention, unwilling to be audio-recorded
Key Trial Info
Start Date :
March 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04833127
Start Date
March 17 2021
End Date
December 31 2022
Last Update
September 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
South African Medical Research Council
Durban, KwaZulu-Natal, South Africa